Stock A000520 SAMIL PHARMACEUTICAL CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

All News Samil Pharmaceutical Co.,Ltd

Equities

A000520

KR7000520007

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-06-09 EDT 		5-day change 1st Jan Change
8,330 KRW +0.36% Intraday chart for Samil Pharmaceutical Co.,Ltd +2.46% +24.33%
05-14 Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-14 Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Samil Pharmaceutical Co.,Ltd announced that it has received KRW 12 billion in funding
CI
Samil Pharmaceutical Co.,Ltd announced that it expects to receive KRW 12 billion in funding
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 30, 2021.
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 30, 2021.
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 30, 2021.
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 30, 2021.
CI
Samil Pharmaceutical Co.,Ltd's Equity Buyback announced on November 30, 2021, has expired with 125,939 shares, representing 0.99% for KRW 997.71 million.
CI
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on October 5, 2021.
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on October 5, 2021.
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on October 5, 2021.
CI
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on October 5, 2021.
CI
Samil Pharmaceutical Co.,Ltd's Equity Buyback announced on October 5, 2021, has expired with 119,560 shares, representing 0.94% for KRW 996.5 million.
CI
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Samil Pharmaceutical Co.,Ltd announced that it has received KRW 4 billion in funding
CI
Samil Pharmaceutical Co.,Ltd announced that it has received KRW 5 billion in funding
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A000520 Stock
  4. News Samil Pharmaceutical Co.,Ltd